These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 21448524

  • 1. Left ventricular hypertrophy in patients with chronic kidney disease under conservative treatment.
    Bregman R, Lemos C, Pecoits Filho R, Abensur H, Draibe S, Bastos MG, Canziani ME.
    J Bras Nefrol; 2010 Mar; 32(1):83-8. PubMed ID: 21448524
    [Abstract] [Full Text] [Related]

  • 2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 Mar; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, Thomopoulos C, Syrseloudis D, Stefanadi E, Mihas C, Katsi V, Papademetriou V, Stefanadis C.
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [Abstract] [Full Text] [Related]

  • 4. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
    Kimura T, Iio K, Obi Y, Hayashi T.
    Nihon Jinzo Gakkai Shi; 2007 Apr; 49(8):1007-13. PubMed ID: 18186229
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.
    Kutlay S, Dincer I, Sengül S, Nergizoglu G, Duman N, Ertürk S.
    Am J Kidney Dis; 2006 Mar; 47(3):485-92. PubMed ID: 16490628
    [Abstract] [Full Text] [Related]

  • 7. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A, Makusidi AM, Kolo PM.
    Ann Afr Med; 2012 Mar; 11(1):21-6. PubMed ID: 22199043
    [Abstract] [Full Text] [Related]

  • 8. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
    Leonardis D, Basta G, Mallamaci F, Cutrupi S, Pizzini P, Tripepi R, Tripepi G, De Caterina R, Zoccali C.
    Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):748-55. PubMed ID: 21470837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A.
    J Ayub Med Coll Abbottabad; 2004 Sep; 16(2):3-8. PubMed ID: 15455608
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML, Salvetti M, Rizzoni D, Monteduro C, Castellano M, Agabiti-Rosei E.
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [Abstract] [Full Text] [Related]

  • 15. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR.
    Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099
    [Abstract] [Full Text] [Related]

  • 16. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, Sanderson JE.
    J Am Soc Nephrol; 2004 Aug 15; 15(8):2186-94. PubMed ID: 15284304
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
    Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):458-63. PubMed ID: 15854551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.